BURCON NUTRASCIENCE CORP (BU.CA) Stock Price, Quote, News and Overview
TSX:BU - Toronto Stock Exchange - CA1208311029 - Common Stock - Currency: CAD
BU.CA Quote, Performance and Key Statistics
TSX:BU (2/21/2025, 7:00:00 PM)
0.095
-0.01 (-7.32%)
The current stock price of BU.CA is 0.095 CAD. In the past month the price increased by 5.56%. In the past year, price decreased by -50%.
BU.CA Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| AIM-PR-C.CA | AIMIA INC - AIMCN 7.773 PERP | N/A | 1.65B | ||
| VNP.CA | 5N PLUS INC | 26.58 | 615.27M | ||
| NEO.CA | NEO PERFORMANCE MATERIALS IN | N/A | 345.86M | ||
| ECO.CA | ECOSYNTHETIX INC | N/A | 298.61M | ||
| AIM.CA | AIMIA INC | N/A | 231.85M | ||
| BPYP-PR-A.CA | Brookfield Property Preferred LP | N/A | 166.19M | ||
| HPQ.CA | HPQ SILICON INC | N/A | 88.74M | ||
| NANO.CA | NANO ONE MATERIALS CORP | N/A | 83.56M | ||
| AUUA.CA | ALUULA COMPOSITES INC | N/A | 16.29M |
Related stock screener links
About BU.CA
Company Profile
Burcon NutraScience Corp. engages in the development of plant proteins and ingredients for use in the food and beverage industries. The company is headquartered in Vancouver, British Columbia. The firm has an extensive patent portfolio covering its novel plant-based proteins derived from pea, canola, soy, hemp and sunflower seeds, among other plant sources. The firm is engaged in the production of hemp protein isolate and provision of contract research services. Its products include hempseed protein, canola protein, pea proteins and protein blends. Its hempseed protein isolate extraction and purification/production process can produce a high-quality protein ingredient that contains 95% pure protein. The company extracts and purifies a canola protein isolate from canola meal. The company has branded this protein isolate under the trade name Puratein C. Peazazz is a soluble, clean and neutral-tasting pea protein. The company provides consulting and contract services, product and process development, and process scale-up and validation.
Company Info
BURCON NUTRASCIENCE CORP
1946 Broadway W
Vancouver BRITISH COLUMBIA V6J 1Z2 CA
CEO: Johann F. Tergesen
Employees: 18
Company Website: https://www.burcon.ca/
Investor Relations: https://burcon.ca/investors/press-releases
Phone: 16047330896
BURCON NUTRASCIENCE CORP / BU.CA FAQ
What is the stock price of BURCON NUTRASCIENCE CORP today?
The current stock price of BU.CA is 0.095 CAD. The price decreased by -7.32% in the last trading session.
What is the ticker symbol for BURCON NUTRASCIENCE CORP stock?
The exchange symbol of BURCON NUTRASCIENCE CORP is BU and it is listed on the Toronto Stock Exchange exchange.
On which exchange is BU.CA stock listed?
BU.CA stock is listed on the Toronto Stock Exchange exchange.
What is BURCON NUTRASCIENCE CORP worth?
BURCON NUTRASCIENCE CORP (BU.CA) has a market capitalization of 13.56M CAD. This makes BU.CA a Nano Cap stock.
How many employees does BURCON NUTRASCIENCE CORP have?
BURCON NUTRASCIENCE CORP (BU.CA) currently has 18 employees.
What are the support and resistance levels for BURCON NUTRASCIENCE CORP (BU.CA) stock?
BURCON NUTRASCIENCE CORP (BU.CA) has a support level at 0.09 and a resistance level at 0.1. Check the full technical report for a detailed analysis of BU.CA support and resistance levels.
Is BURCON NUTRASCIENCE CORP (BU.CA) expected to grow?
The Revenue of BURCON NUTRASCIENCE CORP (BU.CA) is expected to decline by -17.09% in the next year. Check the estimates tab for more information on the BU.CA EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy BURCON NUTRASCIENCE CORP (BU.CA) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of BU.CA, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of BU.CA, evaluating the profitability, health, valuation and growth aspects
- BURCON NUTRASCIENCE CORP (BU.CA) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- BURCON NUTRASCIENCE CORP (BU.CA) Sales and EPS estimates to see what analysts future expectations are.
- BURCON NUTRASCIENCE CORP (BU.CA) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- BURCON NUTRASCIENCE CORP (BU.CA) Insider and Institutional Ownership to learn about the owners and their transactions.
- BURCON NUTRASCIENCE CORP (BU.CA) Stock Chart to make your own analysis
- BURCON NUTRASCIENCE CORP (BU.CA) Latest news and press-releases to stay up to date.
Does BURCON NUTRASCIENCE CORP (BU.CA) stock pay dividends?
BU.CA does not pay a dividend.
When does BURCON NUTRASCIENCE CORP (BU.CA) report earnings?
BURCON NUTRASCIENCE CORP (BU.CA) will report earnings on 2025-06-24, after the market close.
What is the Price/Earnings (PE) ratio of BURCON NUTRASCIENCE CORP (BU.CA)?
BURCON NUTRASCIENCE CORP (BU.CA) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.06).
BU.CA Technical Analysis
ChartMill assigns a technical rating of 2 / 10 to BU.CA. When comparing the yearly performance of all stocks, BU.CA is a bad performer in the overall market: 94.46% of all stocks are doing better.
BU.CA Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to BU.CA. BU.CA has a bad profitability rating. Also its financial health evaluation is rather negative.
BU.CA Financial Highlights
Over the last trailing twelve months BU.CA reported a non-GAAP Earnings per Share(EPS) of -0.06. The EPS increased by 72.59% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -87.03% | ||
| ROE | -502.81% | ||
| Debt/Equity | 0.66 |
BU.CA Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 84% to BU.CA. The Buy consensus is the average rating of analysts ratings from 9 analysts.
For the next year, analysts expect an EPS growth of 37.38% and a revenue growth -17.09% for BU.CA